Latest News

With tariff enforcement in the US Trump administration’s second term tightening and Korean exporters facing higher compliance and legal risks, attention is turning to companies that keep production and supply chains closer to home. This article looks at how that backdrop could affect US equities in manufacturing, logistics, and industrial production, and why some investors are reassessing exposure to domestic supply chain beneficiaries. Below, three stocks from a US Domestic Supply Chain...

In recent weeks, Frontline Plc has seen a shift in its shareholder base, with institutional ownership easing to 29.60% while the stock’s technical indicators and moving averages shifted largely to buy signals within the Oil & Gas Related Equipment and Services industry. Despite this institutional pullback, Frontline now ranks first in its industry for price momentum and carries a moderate risk profile with very low beta, highlighting a mix of strong trading interest and relatively muted...

The Tate & Lyle takeover by US-based Ingredion has turned the spotlight onto consumer staples stocks that could sit on the path of the next merger or acquisition. A £2.7b price tag, a 60% premium to pre-deal speculation levels and plans for a combined $9.9b revenue base are a clear reminder that scale, cost cutting and product portfolios are firmly in focus. This article looks at 3 stocks that appear directly exposed to the same set of forces, helping you decide whether these M&A currents...

Recent attention on Ingersoll Rand (IR) follows its solid first quarter 2026 report, where revenue and orders grew and the book to bill ratio stayed above one for the full year since 2022. See our latest analysis for Ingersoll Rand. Ingersoll Rand’s recent first quarter report and continued positive book to bill ratio seem to have supported a 9.87% 1 month share price return, even though the 1 year total shareholder return is slightly down and the 3 year figure remains clearly positive. This...

Arqit Quantum (NasdaqCM:ARQQ) has agreed to a US$7 million settlement resolving all U.S. securities class actions, closing multi year disputes over alleged misstatements about its quantum encryption technology and revenue sources. See our latest analysis for Arqit Quantum. The recent 7 day share price return of 79.3%, including a 7.9% move in the last session to US$24.38, suggests momentum has picked up quickly, even though the 1 year total shareholder return is still down 41.5% and the 5...

Investors in Speedy Hire Plc ( LON:SDY ) had a good week, as its shares rose 8.4% to close at UK£0.21 following the...

Telekom Austria AG ( VIE:TKA ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is two business days...

MFF Capital Investments (ASX:MFF) is back in focus after flagging a planned 23% lift in its FY26 dividend. This continues a pattern of annual dividend increases since 2018 that keeps income-focused investors watching closely. See our latest analysis for MFF Capital Investments. MFF Capital Investments’ recent dividend update comes after a period of strong price momentum, with a 90 day share price return of 15.91% and a 1 year total shareholder return of 23.99% supporting a much stronger 3...

Nicolet Bankshares (NIC) is back in focus after reporting quarterly results that surpassed analyst expectations on revenue and earnings, yet the stock has fallen about 6.5% since the release. See our latest analysis for Nicolet Bankshares. At a share price of $146.85, Nicolet Bankshares has a year to date share price return of 21.88%, while its 1 year total shareholder return of 26.99% and 3 year total shareholder return of 123.40% point to momentum that has eased slightly in the very short...

Markets are sending mixed signals right now, with pockets of resilient consumer demand, shifting inflation trends, and central banks adjusting policy in places like Russia and Japan. In this kind of cross-current, many investors are looking at companies where growth expectations are supported not only by analysts but also by management that has meaningful skin in the game. The Fast Growing Stocks With High Insider Ownership screener focuses exactly on that combination. In this article, you...

Coca-Cola FEMSA, S.A.B. de C.V. recently declared a quarterly dividend of US$0.9973 per share payable on July 24, 2026, while also confirming a board change with Sedef Salingan Sahin replacing Jennifer K. Mann as a Series D director earlier in June. These moves, alongside recent improvements in revenue and net profit, highlight how the bottler is coupling capital returns with governance continuity and operating strength. With this combination of a higher cash payout and steady operations,...

Recently, Rayonier Inc. reported a valuation score of 8.90, placing it 52nd out of 191 Residential & Commercial REITs, alongside a P/E ratio of 6.90, while institutional shareholdings rose as major investors such as Cohen & Steers Capital Management and BlackRock increased their positions and Mason Hawkins remained the largest holder despite slightly reducing its stake. This combination of a relatively low earnings multiple and rising institutional ownership suggests that professional...

The U.S. and Iran recently signed an interim agreement that waives some sanctions on Tehran’s oil and reopens the Strait of Hormuz, starting a 60-day negotiation on a broader lifting of oil sanctions. This development could increase global crude supply, raising questions for U.S. shale producers like Chord Energy whose revenues are closely tied to benchmark oil prices. We’ll now look at how the prospect of additional Iranian barrels affecting global supply might reshape Chord Energy’s...

In June 2026, Howmet Aerospace Inc. closed three long-standing ESOP-related shelf registrations and withdrew a smaller 2019 ESOP shelf, simplifying its equity offering framework around employee stock ownership plans. This cleanup of legacy ESOP shelves, alongside stronger margins, higher earnings and portfolio reshaping, underlines management’s focus on efficiency and higher-return business areas. We’ll now examine how this emphasis on higher-margin aerospace content and operational...

BioGaia (OM:BIOG B) has drawn fresh investor attention after expanding its BioGaia Skincare portfolio with two microbiome-focused products for babies and children, along with updated packaging and recent launches in China and the US. See our latest analysis for BioGaia. The new skincare launches arrive after a mixed period for BioGaia’s stock, with the share price at SEK118.2, a 30 day share price return down 9.7% but a year to date share price return of 12.57% and a 1 year total shareholder...

Hope Bancorp (HOPE) has drawn fresh attention after institutional ownership climbed to 103.24%, while the latest quarter showed revenue up 26.53% and net profit up 40.03% year over year. See our latest analysis for Hope Bancorp. At a share price of $12.84, Hope Bancorp has a 90 day share price return of 16.20% and a 1 year total shareholder return of 32.86%. This points to firming momentum as recent revenue and profit figures, higher institutional ownership, and improving financial health...

SkyWest (SKYW) is back in focus for investors after recent share price moves and updated valuation metrics, prompting a closer look at how its returns, earnings profile and current US$92.63 price interact. See our latest analysis for SkyWest. Recent trading has been mixed for SkyWest, with the 1 month share price return of 9.21% contrasting with a year to date share price decline of 8.47% and a 3 year total shareholder return of 134.09%. This suggests that longer term holders have seen...

In recent months, First Commonwealth Financial Corp reported strong year-over-year gains in revenue and net profit, alongside improved operating efficiency and a solid overall financial health profile within the U.S. banking services industry. An interesting development is that institutional investors now hold over three-quarters of the company’s shares, with firms like BlackRock and State Street modestly increasing their positions, signaling growing professional interest in the bank’s...

Today is shaping up negative for Afrimat Limited ( JSE:AFT ) shareholders, with the analysts delivering a substantial...

In recent days, Envista Holdings Corp has seen growing institutional ownership, a high valuation multiple, and technical indicators pointing to positive price momentum, all within a relatively low-beta risk profile in the Healthcare Equipment & Supplies industry. An interesting angle is Envista’s combination of a very high institutional shareholding score with limited disclosed valuation metrics beyond its P/E ratio, leaving some aspects of market expectations less transparent. We’ll now...

The closure and partial reopening of the Strait of Hormuz has pushed energy security and global trade routes back to center stage, and that matters for stocks plugged into ports, shipping and logistics. When oil flows are disrupted or rerouted, some companies face higher costs and operational headaches, while others see volumes and pricing power shift in their favor. This article looks at how that tension filters through to investors by focusing on 3 stocks from our Global Infrastructure and...

Why InnoCare Pharma Stock Is In Focus After EHA 2026 InnoCare Pharma (SEHK:9969) has drawn fresh attention after presenting data from more than 40 clinical studies of its BTK inhibitor orelabrutinib at the European Hematology Association 2026 Congress. The company highlighted outcomes across several hematological cancers, including chronic lymphocytic leukemia, small lymphocytic lymphoma, marginal zone lymphoma, mantle cell lymphoma, diffuse large B cell lymphoma, and primary central nervous...

Maximus (MMS) has drawn investor attention after its recent share performance, with the stock down 6.1% over the past day and 10.5% over the past week, prompting fresh scrutiny of its government-services business. See our latest analysis for Maximus. Zooming out, Maximus has experienced fading momentum, with the share price down 18.7% over the past 90 days and the 1 year total shareholder return declining 15.4%. This signals a weaker appetite for the stock despite its government-services...

Recent Share Performance and Business Scale Quest Diagnostics (DGX) has seen its stock decline about 1.4% over the past day and roughly 4% over the past week, while returns over the past month and past 3 months are close to flat. Despite these short term moves, the company operates at considerable scale, with revenue of about $11.3b and net income of roughly $1.0b, and a market value near $21.6b based on the latest figures. See our latest analysis for Quest Diagnostics. At a share price of...